We are live on ! Find out more
Creative Planning

Creative Planning Portfolio holdings

AUM $147B
1-Year Est. Return 18.73%
This Fund
S&P 500
This Quarter Est. Return
+8.06%
1 Year Est. Return
+18.73%
3 Year Est. Return
+48.71%
5 Year Est. Return
+44.71%
10 Year Est. Return
+145.34%
AUM
$66.5B
AUM Growth
+$8.68B
Cap. Flow
+$4.4B
Cap. Flow %
6.62%
Top 10 Hldgs %
43.86%
Holding
2,667
New
353
Increased
1,277
Reduced
719
Closed
180

Sector Composition

Rank Sector Weight
1 Technology 4.02%
2 Financials 2.97%
3 Healthcare 1.72%
4 Consumer Discretionary 1.4%
5 Consumer Staples 1.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MSFT icon
2226
PUT
Microsoft
MSFT
$2.84T
$51.2K ﹤0.01%
13,300
-2,000
-13% -$480K
SGMO
2227
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$50.4K ﹤0.01%
16,040
+1,061
+7% +$4.12K
DBD
2228
DELISTED
Diebold Nixdorf Incorporated
DBD
$50K ﹤0.01%
35,242
+197
+0.6% +$423
GDRX icon
2229
GoodRx Holdings
GDRX
$1B
$49.9K ﹤0.01%
+10,717
New +$52.8K
GLDG
2230
GoldMining Inc
GLDG
$179M
$49.1K ﹤0.01%
43,472
+30,130
+226% +$31.6K
FCRD
2231
DELISTED
First Eagle Alternative Capital BDC, Inc. Common Stock
FCRD
$49K ﹤0.01%
+11,500
New +$47.5K
ADAM
2232
Adamas Trust
ADAM
$777M
$49K ﹤0.01%
+4,784
New +$51K
NEM icon
2233
CALL
Newmont
NEM
$98.2B
$48.6K ﹤0.01%
11,000
+1,000
+10% +$44.6K
MRKR icon
2234
Marker Therapeutics
MRKR
$20.3M
$48.3K ﹤0.01%
18,164
INO icon
2235
Inovio Pharmaceuticals
INO
$79.8M
$47.9K ﹤0.01%
2,557
+1,547
+153% +$35.1K
JOBY icon
2236
Joby Aviation
JOBY
$6.82B
$47.6K ﹤0.01%
14,203
+500
+4% +$2.03K
VXRT
2237
DELISTED
Vaxart
VXRT
$47.6K ﹤0.01%
49,500
+20,999
+74% +$29.7K
FOSL icon
2238
Fossil Group
FOSL
$239M
$46.5K ﹤0.01%
10,786
-823
-7% -$3.44K
FSP
2239
Franklin Street Properties
FSP
$44.8M
$46.1K ﹤0.01%
+16,883
New +$46.7K
SRNE
2240
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$45.5K ﹤0.01%
51,362
-1,321
-3% -$1.75K
OPEN icon
2241
Opendoor
OPEN
$3.7B
$44.9K ﹤0.01%
40,000
+20,370
+104% +$39.1K
BTMD icon
2242
Biote Corp
BTMD
$69.2M
$43.3K ﹤0.01%
11,599
BCLI
2243
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
$42.1K ﹤0.01%
1,712
-333
-16% -$12.4K
GRWG icon
2244
GrowGeneration
GRWG
$82.9M
$41.6K ﹤0.01%
10,609
-5,354
-34% -$25.5K
FSM icon
2245
Fortuna Silver Mines
FSM
$2.59B
$41.4K ﹤0.01%
+11,050
New +$36.5K
SPY icon
2246
CALL
State Street SPDR S&P 500 ETF Trust
SPY
$778B
$41K ﹤0.01%
1,200
-900
-43% -$346K
SRVR icon
2247
Pacer Data & Infrastructure Real Estate ETF
SRVR
$379M
$40.8K ﹤0.01%
+1,405
New +$40.7K
SID icon
2248
Companhia Siderúrgica Nacional
SID
$1.43B
$40K ﹤0.01%
+14,488
New +$39K
SER icon
2249
Serina Therapeutics
SER
$31M
$39.9K ﹤0.01%
2,057
GTM
2250
CALL
ZoomInfo Technologies
GTM
$861M
$39.9K ﹤0.01%
7,000

Similar funds

Creative Planning's Q4 2022 Portfolio in Review

As of Q4 2022, Creative Planning held 2,667 positions worth $66.5B, up 15% from $57.8B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Creative Planning deployed $4.4B of net new capital in Q4 2022, opening 353 new positions and adding to 1,277 existing holdings. Its largest new stake was Avantis US Equity ETF: 4,140,930 shares worth $282M.

By sector, the portfolio is most concentrated in Technology at 4% of assets, down from 4.4% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was State Street SPDR Portfolio S&P 500 ETF, an estimated $76.1M trimmed.

  • Creative Planning's largest Q4 2022 buy was Avantis US Equity ETF: 4,140,930 shares worth $282M.
  • Creative Planning added most to iShares Core MSCI International Developed Markets ETF in Q4 2022, an estimated $322M increase.
  • Creative Planning's biggest Q4 2022 reduction was State Street SPDR Portfolio S&P 500 ETF, cutting an estimated $76.1M.
  • Creative Planning fully exited Veradigm Inc. Common Stock in Q4 2022, selling an estimated $19.6M.
  • Creative Planning's ten largest holdings make up 44% of its $66.5B portfolio in Q4 2022.
  • Creative Planning opened 353 new positions and closed 180 in Q4 2022.
  • Creative Planning's portfolio value rose 15% quarter-over-quarter to $66.5B.

Based on Creative Planning's 13F filing for Q4 2022, filed 10 Feb 2023.